ARCHIVES

Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future

This article is from The Cancer Letter archive.

Vol. 22 No. 09 | March 1, 1996

Download PDF Visit The Full Archive

Related Articles

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

October 26, 2001

NCI Director John Niederhuber Favors Hands-On Management, Revives Institute’s Former Organizational Structure, Abandons Senior Management Team to Work Closely With Deputies and Division Directors.

September 22, 2006

NIH “Just In Time” Procedure Expanded For Two Awards

April 12, 1996

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984